News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Walk News

Click on a headline to read the latest about Parkinson's Unity Walk. 

Over $1.5 Million in Donations Raised by the 2018 Parkinson's Unity Walk Now Funding Research

The Parkinson Alliance Announces Debbie Ayers as Event Manager for the Parkinson’s Unity Walk

The 24th Annual Parkinson’s Unity Walk Raised Over $1.5 Million for Parkinson’s Disease Research

Top 50 Teams - Parkinson's Unity Walk 2018

2018 PUW Favorite Walk Moments

Submit Your Favorite Walk Moments from the 2018 Parkinson's Unity Walk

Drop Off Your Team T-shirt on Walk Day for Inclusion in the PUW Memory Quilt

Come Connect with Others at Sunovion’s Parkinson’s Educational Breakfast Program Before the Unity Walk!

The 24th Parkinson’s Unity Walk to Take Place on Saturday, April 28th in New York City’s Central Park to Raise Funds for Research

ATTENTION Returning Team Captains: Important News About Your 2018 Team Page

The Parkinson's Unity Walk mourns the loss of Dr. Robert Burke

Parkinson's Unity Walk Elects New Board Member; Announces New Roles for Two Board Members

The Parkinson's Unity Walk mourns the loss of Lupe McCann

2018 Light of Day Winterfest Will Kick Off Fundraising in NJ

The 23rd Parkinson’s Unity Walk Raised Over $1.5 Million in Donations for Parkinson’s Disease Research

Top 50 Teams - Parkinson's Unity Walk 2017

The 23rd Parkinson’s Unity Walk to Take Place on Saturday, April 22nd in New York City’s Central Park

Letter on Health Care Reform to President-Elect Trump from Patient Advocacy Organizations

Your Dollars at Work – 2016 PUW Research Grants Have Been Awarded

2016 PUW Memory Quilt is Awarded to Rockin’ Roses

The 22nd Parkinson’s Unity Walk Raised More Than $1.4 Million for Parkinson’s Research

Top 50 Teams - Parkinson's Unity Walk 2016

Muhammad Ali, Truly the "Greatest"

Favorite Walk Moments from the 2016 Parkinson's Unity Walk

Team Photos from the 22nd Parkinson's Unity Walk

Submit Your Favorite Walk Moments from the 22nd Unity Walk

Attendees at the 22nd Parkinson’s Unity Walk Will Find Valuable New Resources for Managing Symptoms of Parkinson’s Disease

back to top

Sponsor & Foundation News

“Milestone Moment” as LRRK2 inhibitor enters human testing

The Parkinson Alliance Presented Patient-Centered Research on Vision and Parkinson’s Disease at American Congress of Rehabilitation Medicine in Dallas, Texas

Adamas Pharmaceuticals Launches “Dyskinesia Is A Jerk™,” a Campaign to Raise Awareness and Highlight the Impact of Parkinson’s Disease Dyskinesia

Parkinson's Foundation Designates Three Centers of Excellence in Parkinson's Care

Sunovion Presents Data from Pivotal Phase 3 Study of Apomorphine Sublingual Film (APL-130277)

Adamas Presents New Data Analysis Demonstrating that GOCOVRI™ Reduces Transitions between Dyskinesia and OFF Episodes Throughout the Day

Medtronic Launches New Clinician Programmer for Deep Brain Stimulation Therapy

Sunovion Announces FDA Acceptance of New Drug Application for Apomorphine Sublingual Film (APL-130277)

Acorda Announces EMA Validation of the MAA Submission for INBRIJA™

Introducing Little Big Things™ from Sunovion Pharmaceuticals Inc.

Adamas Announces Multiple Data Presentations at the American Academy of Neurology Annual Meeting

Sunovion Submits New Drug Application to the FDA for Apomorphine Sublingual Film for the Treatment of OFF Episodes Associated with PD

Adamas Announces Publication of Data Supporting the Benefits of GOCOVRI™ in Parkinson’s Disease Patients with Dyskinesia

Lundbeck to acquire Prexton Therapeutics

Acorda Launches New Initiative - “Live Well. Do Tell.™” to Support People with Parkinson’s

Nuplazid and Clozaril Are Most Reliable Parkinson’s Psychosis Therapies, Review Finds

Acorda Announces FDA Acceptance of New Drug Application for INBRIJA™

Adamas Announces Publication of Amantadine Immediate Release Subgroup Analysis from EASE LID 2 Open-label Study

Sunovion Announces Positive Results from Study of Apomorphine Sublingual Film in Patients with PD

Adamas Announces U.S. Commercial Launch of GOCOVRI™ the First and Only FDA Approved Medication for the Treatment of Dyskinesia in Parkinson's Disease Patients

Boston Scientific Receives U.S. FDA Approval for the Vercise™ Deep Brain Stimulation System

Acorda Resubmits NDA for Parkinson's Disease Candidate Inbrija

Acorda Resubmits New Drug Application for INBRIJA™ (CVT-301, levodopa inhalation powder)

Voyager Therapeutics Highlights Lead Program VY-AADC for Advanced PD

Voyager’s AADC Gene Therapy Shows Promise as Maintenance Therapy for Parkinson’s Disease

GOCOVRI for Dyskinesia Gets Orphan Drug Designation

Distinguished Movement Disorders Researchers to Lead Fresco Institute at NYU Langone Health

New Phase 3 Trial to Test Nuplazid for Parkinson’s Psychosis in Array of Dementia Patients

Voyager Therapeutics Presents Promising Parkinson’s Data

Adamas Announces FDA Approval of GOCOVRI™ as First and Only Medication for the Treatment of Dyskinesia in Parkinson’s Disease Patients

Acorda Therapeutics Announces FDA Approval of INBRIJA™ (levodopa inhalation powder) (December 21, 2018)

back to top

News in the Parkinson's Disease Community

Axovant Announced Administration of AXO-Lenti-PD, A Novel Gene Therapy for Patient’s with Parkinson’s Disease, to First Patient in Clinical Study

NYC Area: Free LSVT-LOUD Educational Seminar on November 30

NYC Area: Free LSVT-LOUD Educational Seminar on December 1

Life with Parkinson’s, Essential Tremor or Dystonia?

Method Developed to Test New Parkinson's Therapies

New Hope for Parkinson’s Disease Cure as Treatment Enters Human Trials

Princeton Ballet School Introduces New Dance Class for People with Parkinson's Disease

Johns Hopkins Startup Neuraly Plans Phase 1 Parkinson’s Trial

UA Clinical Trial to Repurpose Ketamine for Parkinson's Patients

Computer Model to Select Parkinson’s Patients Who Benefit Most from Deep Brain Stimulation

Experimental Drug Stops Parkinson's Disease Progression in Mice

Parkinson's Disease May Soon Be Treated with Blood Pressure Drug

FDA Grants RMAT Designation for VY-AADC for Parkinson's Disease

A Clinical Trial of Nilotnib in People Living with Parkinson’s Disease

The Apple Watch Will Monitor Symptoms of Parkinson's Disease

Deep Brain Stimulation Device That Can Self-Tune Shows Promise in Small Parkinson’s Study

Phase 1 Trial Finds Potential Parkinson’s Vaccine, Affitope PD01A, to be Safe and Possibly Effective

Scientists Just Found an Unexpected Link Between Tuberculosis and Parkinson's Disease

FDA Continues Crack Down on Unapproved Stem Cell Clinics

Researchers Find That Lipid Accumulation in the Brain may be an Early Sign of Parkinson's Disease

Experts Weigh the Benefits of New Parkinson’s Drugs

Targeting New Compound Slows Parkinson’s Disease in Rats

Two Markers of Parkinson’s Progression May Help Trials in Newly Diagnosed Patients

Educational Program on Medical Marijuana and Other Emerging Therapies in the Treatment of PD

Biomarkers Identified That Could Help Predict Individuals at Risk for Parkinson’s Disease

New Parkinson’s Collaboration Is Exactly What’s Needed, Editorial Says

NYU Langone Parkinson’s Program

Act Now: Urge Congress to Fund a National Parkinson’s Database

NIH Scientists Adapt New Brain Disease Test for Parkinson’s, Dementia with Lewy Bodies

Breakthrough Refinement of the Parkinson's Disease Exercise Prescription

Brainstem Changes Identified in Parkinson’s Disease

Parkinson’s Protein Aggregates Seen in Action Destroying Neurons in Brain

Study Shows That Parkinson's Disease Progression Can Be Slowed with Vigorous Exercise

Acadia Launches Parkinson’s Campaign to Shine Light on Psychosis Symptoms

Low-Frequency Deep Brain Stimulation Found to Improve Cognition in Parkinson’s Disease Patients

Ultrasound Could Offer Noninvasive Treatment for Parkinson’s and Depression

Scientists Reveal Breakthrough in Brain Cell Repair Around Parkinson’s Disease

Veterans’ Coverage of Agent Orange-Related Diseases Delayed

OHSU Study Validates Deep Brain Surgery While Asleep for Parkinson's Patients

Insightec Gets FDA Blessing for Study of Exablate Neuro to Treat Parkinson’s Involuntary Movements

New UMass Lowell Study to Explore Link Between Gut Bacteria and Parkinson's Disease

Deep Sleep Linked to Cognitive Performance in People Living with Parkinson's

First Patient Treated with Titan Pharmaceuticals' Subdermal Implant for Parkinson's Disease

back to top